Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yarrow BioscienceYARW -2.78%13 Interest Coverage is No Debt (1) as of Jun. 2026, which is 100% below its 10-year median of 10,000.00. GuruFocus rates YARW with a GF Score™ of 13/100. Among 367 Biotechnology companies, Yarrow Bioscience ranks better than 98.91% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Yarrow Bioscience's
Operating Income
for the
three
months ended in Jun. 2026 was $-3.10 Mil. Yarrow Bioscience's Interest Expense for the
three
months ended in Jun. 2026 was $0.00 Mil.
Yarrow Bioscience has no debt.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Yarrow Bioscience Inc has no debt.
(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
The historical rank and industry rank for Yarrow Bioscience's Interest Coverage or its related term are showing as below:
YARW'
s Interest Coverage Range Over the Past 10 Years
Min: No Debt Med: No Debt Max: No Debt
Current: No Debt
YARW's Interest Coverage is ranked better than 98.91% of 367
companies
in the Biotechnology industry
Industry Median: 104.07
vs YARW: No Debt
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Yarrow Bioscience Interest Coverage Related Terms
Yarrow Bioscience Interest Coverage Historical Data
* Premium members only.
The historical data trend for Yarrow Bioscience's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Yarrow Bioscience Interest Coverage Chart
Yarrow Bioscience Annual Data
Trend
Dec25
Interest Coverage
No Debt
Yarrow Bioscience Quarterly Data
Jun25
Dec25
Mar26
Jun26
Interest Coverage
No Debt
No Debt
No Debt
No Debt
YARW vs CGTX, RANI, VRCA: Interest Coverage Comparison
For the Biotechnology subindustry, Yarrow Bioscience's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yarrow Bioscience Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Yarrow Bioscience's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Yarrow Bioscience's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of No Debt <sup>(1)</sup> mean?
Yarrow Bioscience (YARW) has a Interest Coverage of No Debt (1) as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Yarrow Bioscience and its competitors. This is 100% below median its historical median of 10,000.00. Over the past decade, Yarrow Bioscience's Interest Coverage has ranged from 10,000.00 to 10,000.00. According to the industry distribution chart, Yarrow Bioscience ranks #4 out of 367 companies in the Biotechnology industry, placing it in the top 1.1%.
Is Yarrow Bioscience's Interest Coverage too high?
Yarrow Bioscience's current Interest Coverage of No Debt (1) is 100% below median its 10-year median of 10,000.00. Over the past 10 years, this metric has ranged from a low of 10,000.00 to a high of 10,000.00. Based on the distribution chart, Yarrow Bioscience ranks #4 out of 367 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Yarrow Bioscience has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Yarrow Bioscience's Interest Coverage compare to CGTX and RANI?
According to the Biotechnology industry distribution chart, Yarrow Bioscience ranks #4 out of 367 companies for Interest Coverage. This places Yarrow Bioscience in the top 1% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 104.07. Historically, Yarrow Bioscience's own Interest Coverage has ranged from 10,000.00 to 10,000.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 104.07, based on 367 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Yarrow Bioscience and its competitors. For the Biotechnology industry, the median Interest Coverage is 104.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yarrow Bioscience's current Interest Coverage is No Debt (1), which is 100% below median its own 10-year median of 10,000.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yarrow Bioscience stock overvalued right now?
Yarrow Bioscience (YARW) has a current Interest Coverage of No Debt (1). The current Interest Coverage is No Debt (1), which is 100% below median its 10-year median of 10,000.00. Yarrow Bioscience's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Yarrow Bioscience (YARW), the current Interest Coverage is No Debt (1) as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.
13GF Score
Get the complete analysis for YARW
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YARW has been successfully added to your 
